PMID: 3748387Sep 1, 1986Paper

Clinical and biochemical studies with controlled-release levodopa/carbidopa

Neurology
J G NuttJ H Carter

Abstract

In five patients with parkinsonism, the optimal dosage of a controlled-release levodopa/carbidopa preparation (CR-3) was three times higher than the dosage of Sinemet and produced higher plasma levodopa concentrations, but did not reduce the fluctuations in plasma levodopa or clinical response. Plasma levodopa concentrations were higher and clinical responses better before the first dose of the day with CR-3. CR-3 treatment benefited two patients, reducing the severity of off periods and off dystonia. Two patients were worse on CR-3 despite higher plasma levodopa levels than those adequate for clinical response to Sinemet or levodopa infusions. CR-3 could benefit a few severely affected patients, but it is necessary to understand the factors that affect absorption of levodopa from sustained-release preparations, as well as the consequences of prolonged elevation of plasma levodopa levels.

Citations

Oct 1, 1993·Movement Disorders : Official Journal of the Movement Disorder Society·J GuridiJ A Obeso
Jul 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·L V MetmanT N Chase
May 1, 1997·Movement Disorders : Official Journal of the Movement Disorder Society·J G NuttW R Woodward
Jan 1, 1996·Journal of Neural Transmission·M GerlachH Przuntek
Nov 26, 2010·Journal of Neurology·Giovanni FabbriniAlfredo Berardelli
Jan 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·S A FactorA M Ingenito
Apr 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·J G NuttT L Trotman
Feb 1, 1990·Journal of Neurology, Neurosurgery, and Psychiatry·J P FrankelG M Stern
Jul 27, 2014·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Raquel de Oliveira VilhenaRoberto Pontarolo
Sep 11, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Stanley Fahn
Jun 1, 1987·Annals of Neurology·J G NuttD Merrick
Jan 1, 1989·Movement Disorders : Official Journal of the Movement Disorder Society·J A ObesoJ M Martínez-Lage
Jun 1, 1988·Annals of Neurology·R KurlanI Shoulson
Jan 1, 1988·Movement Disorders : Official Journal of the Movement Disorder Society·G PezzoliG Scarlato
Jan 1, 1988·Annals of the New York Academy of Sciences·T W HoodH S Greenberg
Jan 1, 1988·Annals of the New York Academy of Sciences·J G Nutt
Oct 1, 1987·Annals of Neurology·M M MouradianT N Chase
Oct 24, 2000·Japanese Journal of Pharmacology·W RaaschP Dominiak
Jun 23, 2012·Neuropharmacology·Philippe HuotJonathan M Brotchie
Nov 1, 1991·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·J T Hutton, J L Morris

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.